Pfizer Ltd. — Regulatory Filings 2024

May 2, 2024

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

May 2, 2024

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“LODR Regulations”), we wish to inform you that, the Company has received an Order dated April 22, 2024 issued by the Assistant Commissioner, GST & Central Excise, Bhubaneswar-II Division Bhubaneswar on May 1, 2024 basis the GST audit conducted for Odisha state for the financial year 2018 – 19 for a Tax demand of Rs. 1,55,19,980/-, Penalty of Rs. 15,51,998/- and interest as per Section 50(1) of Central Goods and Services Tax Act, 2017 & State Goods and Services Tax Act, 2017 read with Section 20(xxv) of the Integrated Goods and Services Tax Act 2017 payable at the time of actual payment of the alleged demand, aggregating to a total demand of Rs. 1,70,71,978/- (excluding interest).

Based on our assessment, we believe that the said demand is not maintainable, and the Company is in the process of preferring an appeal against the said Order. The Order has no material impact on the financials, operations or other activities of the Company.

Additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023 are enclosed as Annexure A.

Please take the above on record.

Thanking you,

Yours truly,

For Pfizer Limited PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2024.05.02 20:12:56 +05'30' Prajeet Nair

Director – Corporate Services & Company Secretary

CIN: L24231MH1950PLC008311 Email ID: contactus.india@pfizer.com Website: www.pfizerltd.co.in

ANNEXURE – A

Information as required under Regulation 30 - Part A of Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Sr.no.	Particulars	Details
1.	Name of Authority Initiating the action/passing the order.	Assistant Commissioner, GST & Central Excise, Bhubaneswar-II Division Bhubaneswar.
2.	Nature and details of the action(s) taken, initiated or order(s) passed.	Order dated April 22, 2024, received on May 1, 2024 under section 73(1) of Central Goods and Services Tax Act, 2017 & State Goods and Services Tax Act, 2017 read with Section 20(xxv) of the Integrated Goods And Services Tax Act 2017 for a Tax demand of Rs. 1,55,19,980/- (Rupees One Crore Fifty Five Lakhs Nineteen Thousand Nine Hundred and Eighty only), Penalty of Rs. 15,51,998/- (Rupees Fifteen Lakhs Fifty One Thousand Nine Hundred and Ninety Eight) and interest as per Section 50(1) of Central Goods and Services Tax Act, 2017 & State Goods and Services Tax Act, 2017 read with Section 20(xxv) of the Integrated Goods and Services Tax Act 2017 payable at the time of actual payment of demand aggregating to aggregating to a total demand of Rs. 1,70,71,978/- (Rupees One Crore Seventy Lakhs Seventy One Thousand Nine Hundred Seventy Eight only), excluding interest.
3.	Date of receipt of direction or order, including any ad-interim or interim orders, or any other communication from the authority	Order dated April 22, 2024 received by the Company on May 1, 2024.
4.	Details of the violation(s) / contravention(s) committed or alleged to be committed.	The Officer has raised the GST demand on account of alleged availment of ineligible input tax credit and non – reversal of input tax credit attributable to exempted supplies by the Company during financial year 2018-19.
5.	Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible	Based on our assessment, we believe that the said demand is not maintainable, and the Company is in the process of preferring an appeal against the said Order. The Order has no material impact on the financials, operations or other activities of the Company.